Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

Feb 24, 2011

30339_dirs_2011-02-24_43516349-da3c-4e2e-b95d-359ca058c865.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-22

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-22 Common Stock A 851.0000 $40.8500 Acquired 57005.9330 Direct
2011-02-22 Common Stock A 625.0000 $40.8500 Acquired 57630.9330 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-22 Stock Option (Right to Buy) $40.8500 A 7420.0000 Acquired 2021-02-22 Common Stock (7420.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 433.5040 Indirect
Common Stock 4236.3364 Indirect

Footnotes

F1: Bonus and incentive shares granted on 02/22/2011.

F2: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2008 that have vested for performance period 7.